Beal, Gaëlle
Barbier, Catherine
Thoret, Sophie
Rubio, Amandine
Bonnet, Mathilde
Mazet, Roseline
Ego, Anne
Pin, Isabelle https://orcid.org/0000-0002-7529-6999
Funding for this research was provided by:
Agir pour les Maladies Chroniques (1)
Article History
Received: 10 April 2019
Accepted: 24 October 2019
First Online: 8 November 2019
Ethics approval and consent to participate
: The protocol was approved by the institutional ethics committee of the Grenoble Alpes University Hospital (Institutional review Board n°38RC14.260), by the French national institution of pharmacovigilance (ANSM, Agence Nationale de Sécurité du Médicament et des produits de santé) (N° Id-RCB: 2014-A01335–42, October 2014), and by the French data protection authority Commission on Information Technology and Liberties (CNIL). Written informed consent was obtained from either parents or guardians.
: Not applicable (anonymous and collective data only).
: The authors declare that they have no competing interest.